Core Viewpoint - Company maintains earnings forecasts for FY25/26 largely unchanged, with current trading at 0.67x/0.63x P/B for FY25/26, and a target price increase of 10% to HKD 8.8, reflecting a significant discount in valuation and attractive dividend yield [1] Financial Performance - For 1H25, company reported a revenue decline of 4% year-on-year to CNY 17.34 billion, while net profit attributable to shareholders increased by 4% to CNY 2.16 billion, achieving an annualized ROE of 8.66%, up 17 percentage points [2] - The dividend payout ratio increased by 4 percentage points year-on-year to 50%, with a stable DPS of HKD 0.25, indicating a slower growth in DPS compared to profit growth due to the dilution effect from convertible bonds [2] Financial Business - Financial business revenue grew by 2% year-on-year to CNY 11.09 billion, accounting for 64% of total revenue, with interest income down by 0.4% to CNY 10.66 billion and consulting fee income up by 167% to CNY 430 million [3] - The net interest margin expanded, with net interest spread and net interest margin increasing by 11 basis points and 4 basis points to 4.06% and 4.51%, respectively [3] - Asset quality remained stable, with non-performing loan ratio slightly decreasing by 0.02 percentage points to 1.05% and the provision coverage ratio remaining stable at 227% [3] Industrial Operations - Industrial operations revenue decreased by 13% year-on-year to CNY 6.33 billion, with a revenue share decline of 4 percentage points to 37% [4] - The overseas business of Hongxin Jianda experienced rapid growth, while domestic market downturn affected overall performance, with Jianda's revenue down 11% to CNY 4.35 billion and net profit down 87% to CNY 35 million [4] - The healthcare segment focused on optimizing management capabilities and cost efficiency, with hospital revenue down 15% to CNY 1.8 billion and net profit down 28% to CNY 110 million, while operational costs decreased by 11% to CNY 1.47 billion [4]

Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Views - The company reported a 3.9% year-on-year decline in revenue for the first half of 2025, totaling 17.336 billion yuan, while net profit attributable to shareholders increased by 3.8% to 2.164 billion yuan [1]. - The financial and consulting business remains a key revenue driver, with a revenue increase of 2.1% year-on-year, while equipment and industrial operations saw declines of 10.7% and 15.5%, respectively [1][17]. - The company has focused on the development of inclusive finance, achieving a 28.7% growth in the asset scale of this business, with revenue soaring by 124.1% year-on-year [3][38]. Summary by Sections Financial Performance - In the first half of 2025, the average return on equity was 8.66%, an increase of 0.17 percentage points year-on-year [1]. - The company’s interest-earning assets stood at 266.626 billion yuan, reflecting a 2.3% increase from the end of the previous year [2]. - The average yield on interest-earning assets rose to 8.08%, while the cost of interest-bearing liabilities decreased to 4.02%, leading to a net interest margin of 4.51% [2][25]. Business Segments - The financial and consulting segment generated 110.90 billion yuan in revenue, accounting for 64.0% of total revenue, with a gross margin of 57.5% [1][19]. - The inclusive finance business achieved a revenue of 14.51 billion yuan, significantly contributing to overall growth [3][38]. Asset Quality - The company reported a non-performing loan ratio of 1.05% and a watchlist ratio of 5.51%, both showing a decline from the previous year [3][36]. - The provision coverage ratio remained stable at 227.33%, indicating solid asset quality [3]. Future Outlook - The company is expected to maintain a high cash dividend payout ratio, with projections for net profit attributable to shareholders of 4.01 billion yuan, 4.23 billion yuan, and 4.48 billion yuan for 2025, 2026, and 2027, respectively [4][5].

Core Viewpoint - Far East Horizon's 1H25 performance met expectations with a revenue decline of 4% year-on-year to 17.34 billion yuan and a net profit increase of 4% year-on-year to 2.16 billion yuan, resulting in an annualized ROE increase of 17 percentage points to 8.66% [1] Financial Performance - The company's financial business revenue increased by 2% year-on-year to 11.09 billion yuan, accounting for 64% of total revenue, with interest income slightly down by 0.4% to 10.66 billion yuan and consulting fee income up by 167% to 430 million yuan [1] - The net interest margin expanded with net interest spread and net interest margin increasing by 11 basis points and 4 basis points to 4.06% and 4.51% respectively, while asset quality remained stable with a non-performing loan ratio of 1.05% [1] Dividend Policy - The company increased its interim dividend payout ratio by 4 percentage points year-on-year to 50%, maintaining a dividend per share (DPS) of 0.25 HKD, indicating a strong dividend yield despite slower growth in DPS compared to profit growth due to dilution from convertible bonds [1] Industry Operations - The company's industrial operations revenue decreased by 13% year-on-year to 6.33 billion yuan, with a decline in domestic business offset by rapid growth in overseas operations [1] - The healthcare segment saw a revenue decline of 15% year-on-year to 1.8 billion yuan, with net profit down by 28% to 110 million yuan, as the company focused on optimizing cost efficiency and expanding non-insurance business [1] Valuation and Forecast - The company maintains its earnings forecast for 25/26e, currently trading at 0.67x/0.63x P/B for 25/26e, with a target price adjustment of 10% to 8.8 HKD, reflecting a significant discount in valuation and attractive dividend expectations [2]

Core Viewpoint - Far East Horizon (03360.HK) announced that it will distribute an interim dividend of HKD 0.25 per share on September 24, 2025 [1] Group 1 - The company will pay an interim dividend of HKD 0.25 per share [1]

Group 1 - The company Far East Horizon (03360) announced a mid-term dividend of HKD 0.25 per share, which will be distributed on September 24, 2025 [1]

EF001 免責聲明 | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | --- | --- | | 股票發行人現金股息公告 | | | 發行人名稱 | 遠東宏信有限公司 | | 股份代號 03360 | | | 多櫃檯股份代號及貨幣 不適用 | | | 04571 相關股份代號及名稱 | FE HORI N2704 | | 05185 | FE HORI N2803 | | 05491 | FE HORI N2810 | | 40722 | UNI TREK B2606 | | 40887 | FE HORI N2610 | | 85008 | FE HORI N2802-R | | 公告標題 | 截至2025年6月30日止六個月之中期股息及暫停辦理股份過戶登記 | | 公告日期 | 2025年8月1日 | | 公告狀態 新公告 | | | 股息信息 | | | 股息類型 | 中期（半年期） | | 股息性質 | 普通股息 | | 財政年末 ...

Core Viewpoint - Far East Horizon (03360) reported a slight decline in total revenue for the first half of 2025, while net profit attributable to ordinary shareholders increased, indicating a focus on maintaining operational quality amidst a challenging environment [1][2]. Financial Performance - The total revenue for the first half of 2025 was RMB 17.336 billion, a decrease of 3.88% year-on-year [1]. - Net profit attributable to ordinary shareholders was RMB 2.164 billion, reflecting a year-on-year increase of 3.77% [1]. - Basic earnings per share stood at RMB 0.51 [1]. Business Segments - The financial and consulting segment achieved revenue of RMB 11.090 billion, with a year-on-year growth of 2.10%, driven by comprehensive services and inclusive finance [1]. - The company maintained a stable non-performing asset ratio, ensuring asset quality remained safe and controllable [1]. - The private equity fund-related financial investments saw a fair value increase of RMB 360 million year-on-year due to capital market support [1]. Operational Strategy - The company emphasized safe and steady operations as a primary task, implementing stricter pre-lease reviews and maintaining high-quality client qualifications [2]. - The industrial operations segment experienced a decline in contribution due to market changes and intensified competition [2].

Core Insights - The company reported a total revenue of RMB 17.336 billion for the first half of 2025, representing a year-on-year decrease of 3.88% [1][2] - Profit attributable to ordinary shareholders increased by 3.77% to RMB 2.164 billion, with basic earnings per share at RMB 0.51 [1] - The financial and consulting segment achieved revenue of RMB 11.09 billion, reflecting a year-on-year growth of 2.10% [1] Financial Performance - The overall revenue for the first half of 2025 was RMB 17.336 billion, showing a slight decline compared to the previous year [2] - The company emphasized operational quality and maintained a cautious approach to business initiatives amid a complex domestic and international environment [2] - The financial business maintained a stable interest rate, supported by comprehensive services and inclusive finance [1][2] Asset Quality and Risk Management - The company implemented a "upward and downward" customer strategy and adhered to prudent risk control policies, resulting in a stable non-performing asset ratio [1] - The asset quality remained secure and controllable, with real and effective performance [1] - The fair value of financial investments related to private equity funds increased by RMB 360 million year-on-year in the first half of 2025 [1] Operational Challenges - The industrial operations segment experienced a decline in contribution due to changes in market conditions and intensified competition [2] - The company adopted stricter pre-lease reviews and maintained high-quality customer qualifications to ensure asset safety and stability [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 （於香港註冊成立的有限公司） （股份代號：3360） 截至二零二五年六月三十日止六個月中期業績公告 遠東宏信有限公司（「本公司」）董事局（「董事局」）謹此公布本公司及其附屬公司 （「本集團」）截至二零二五年六月三十日止六個月的未經審核中期業績，連同截至 二零二四年六月三十日止六個月的比較數字。本公告列載本公司二零二五年中期 報告全文，並符合香港聯合交易所有限公司證券上市規則有關中期業績初步公告 附載的資料之要求。 承董事局命 遠東宏信有限公司 主席、行政總裁及執行董事 孔繁星 香港，二零二五年八月一日 於本公告日期，本公司的執行董事為孔繁星先生（主席）、王明哲先生及曹健先 生；本公司非執行董事為陳樹民先生、衛濛濛女士、劉海峰先生、郭明鑑先生及 羅強先生；以及本公司獨立非執行董事為韓小京先生、劉嘉凌先生、葉偉明先生 及黃家輝先生。 | 企 目 業 信 錄 息 | 公 司 簡 介 | 業 績 概 覽 | 管 ...

Group 1 - The top three companies with the highest short positions are WuXi AppTec (02359), CATL (03750), and COSCO Shipping Holdings (01919), with short ratios of 23.99%, 17.39%, and 14.14% respectively [1][2] - The companies with the largest increase in short positions are Giant Biogene (02367), WuXi AppTec (02359), and Henderson Land Development (00012), with increases of 2.05%, 1.43%, and 1.41% respectively [1][2] - The companies with the largest decrease in short positions are SF Holding (06936), Far East Horizon (03360), and Jiumaojiu International Holdings (09922), with decreases of -1.94%, -1.22%, and -1.18% respectively [1][3] Group 2 - The top ten companies with the highest short ratios include Ganfeng Lithium (01772) at 13.09%, Xiexin Technology (03800) at 12.57%, and Shandong Gold (01787) at 12.35% [2] - The companies with the largest increase in short ratios also include Fuyou Glass (06865) at 12.07% and Tigermed (03347) at 9.81% [2] - The companies with the largest decrease in short ratios include Vanke Enterprise (02202) at 11.38% and Green Leaf Pharmaceutical (02186) at 11.96% [3][4]